+

WO2002088169A3 - Preparation of glucocorticosteroids, 16, 17 acetals or ketals of pregnane derivatives - Google Patents

Preparation of glucocorticosteroids, 16, 17 acetals or ketals of pregnane derivatives Download PDF

Info

Publication number
WO2002088169A3
WO2002088169A3 PCT/SE2002/000814 SE0200814W WO02088169A3 WO 2002088169 A3 WO2002088169 A3 WO 2002088169A3 SE 0200814 W SE0200814 W SE 0200814W WO 02088169 A3 WO02088169 A3 WO 02088169A3
Authority
WO
WIPO (PCT)
Prior art keywords
glucocorticosteroids
preparation
ketals
acetals
pregnane derivatives
Prior art date
Application number
PCT/SE2002/000814
Other languages
French (fr)
Other versions
WO2002088169A2 (en
Inventor
Joergen Blixt
Bengt Aaslund
Original Assignee
Astrazeneca Ab
Joergen Blixt
Bengt Aaslund
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab, Joergen Blixt, Bengt Aaslund filed Critical Astrazeneca Ab
Priority to AU2002307602A priority Critical patent/AU2002307602A1/en
Publication of WO2002088169A2 publication Critical patent/WO2002088169A2/en
Publication of WO2002088169A3 publication Critical patent/WO2002088169A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

Processes for the preparation of compounds of formula (I) involving transacetalisation of the relevant acetonide, or esterification of a compound of formula (I) wherein X is OH. Compounds of formula (I) may be anti-inflammatory, immunosupressive and anti-allergic glucocorticosteroids useful as therapeutic agents.
PCT/SE2002/000814 2001-04-27 2002-04-24 Preparation of glucocorticosteroids, 16, 17 acetals or ketals of pregnane derivatives WO2002088169A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002307602A AU2002307602A1 (en) 2001-04-27 2002-04-24 Preparation of glucocorticosteroids, 16, 17 acetals or ketals of pregnane derivatives

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0110411A GB0110411D0 (en) 2001-04-27 2001-04-27 Chemical process
GB0110411.6 2001-04-27

Publications (2)

Publication Number Publication Date
WO2002088169A2 WO2002088169A2 (en) 2002-11-07
WO2002088169A3 true WO2002088169A3 (en) 2003-01-09

Family

ID=9913626

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/SE2002/000814 WO2002088169A2 (en) 2001-04-27 2002-04-24 Preparation of glucocorticosteroids, 16, 17 acetals or ketals of pregnane derivatives

Country Status (3)

Country Link
AU (1) AU2002307602A1 (en)
GB (1) GB0110411D0 (en)
WO (1) WO2002088169A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010003698A (en) 2007-10-04 2010-04-21 Astrazeneca Ab Steroidal [3, 2-c] pyrazole compounds, with glucocorticoid activity.
WO2009108118A1 (en) * 2008-02-27 2009-09-03 Astrazeneca Ab 16 alpha, 17 alpa-acetal glucocorticosteroidal derivatives and their use
JP2011513469A (en) * 2008-03-13 2011-04-28 ファルマビオス ソシエタ ペル アチオニ Process for producing pregnane derivatives
UY32520A (en) 2009-04-03 2010-10-29 Astrazeneca Ab COMPOUNDS THAT HAVE AGONIST ACTIVITY OF THE GLUCOCORTICOESTEROID RECEPTOR

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1405519A (en) * 1973-07-18 1975-09-10 American Cyanamid Co Triamcinolone derivative
EP0355859A1 (en) * 1985-04-04 1990-02-28 Aktiebolaget Draco Process for the preparation of intermediates for 11-beta,16-alpha,17-alpha,21-tetrahydroxypregna-3,20-dione 16-alpha,17-alpha-acetals and 21-esters thereof
WO1992013872A1 (en) * 1991-02-04 1992-08-20 Aktiebolaget Astra Novel steroids
JPH07277987A (en) * 1994-04-05 1995-10-24 Green Cross Corp:The Steroid anti-inflammatory agent for external use

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1405519A (en) * 1973-07-18 1975-09-10 American Cyanamid Co Triamcinolone derivative
EP0355859A1 (en) * 1985-04-04 1990-02-28 Aktiebolaget Draco Process for the preparation of intermediates for 11-beta,16-alpha,17-alpha,21-tetrahydroxypregna-3,20-dione 16-alpha,17-alpha-acetals and 21-esters thereof
WO1992013872A1 (en) * 1991-02-04 1992-08-20 Aktiebolaget Astra Novel steroids
JPH07277987A (en) * 1994-04-05 1995-10-24 Green Cross Corp:The Steroid anti-inflammatory agent for external use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE CAPLUS [online] AKABOSHI FUMIHIKO ET AL.: "Topical pharmaceutical compositions contating anntiinflammatory steroids", XP002954685, accession no. STN Database accession no. 1996:38628 *

Also Published As

Publication number Publication date
WO2002088169A2 (en) 2002-11-07
GB0110411D0 (en) 2001-06-20
AU2002307602A1 (en) 2002-11-11

Similar Documents

Publication Publication Date Title
CA2417825A1 (en) 6.alpha., 9.alpha.-difluoro-17.alpha.-`(2-furanylcarboxyl)oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent
AUPQ966400A0 (en) Method of graphically defining a formula
WO2001047928A3 (en) Imidazo 1,3,5 triazinones and the use thereof
HUP0300592A3 (en) Process for the preparation of 2-halobenzoic acid derivatives
AU2002361265A1 (en) Pharmaceutical composition for the treatment of psoriasis and other skin diseases
WO2003009803A3 (en) Method of improving cognitive function
WO2002070525A3 (en) Nitrogen-based camptothecin derivatives
AU3841499A (en) Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
AU2001282174A1 (en) Method for the production of xylitol
AU2002234603A1 (en) Method for the manufacture of micro structures
WO2000069255A8 (en) Anti-inflammatory therapy for inflammatory mediated infection
WO2002011737A3 (en) Anti-inflammatory medicament
MY128392A (en) 6ALPHA, 9ALPHA-DIFLUORO-17ALPHA-(2-FURANYLCARBOXYL)OXY]-11ß-HYDROXY-16ALPHA-METHYL-3-OXO-ANDROST-1,4,-DIENE-17-CARBOTHIOIC ACID S-FLUOROMETHYL ESTER AS AN ANTI-INFLAMMATORY AGENT
WO2002088169A3 (en) Preparation of glucocorticosteroids, 16, 17 acetals or ketals of pregnane derivatives
WO2003047505A3 (en) Topoisomerase poison agents
AU2001280270A1 (en) Method of manufacturing structural members and the members provided by such method
AU2001263326A1 (en) Method for altering the fertility of plants
WO2003053337A3 (en) Therapeutic compositions
AU2001242376A1 (en) Process for the preparation of 2-hydroxy-4-methylthiobutyric acid esters
WO2001018025A3 (en) 17alpha propynyl 11-aryl steroids
AU2001262226A1 (en) Process for the preparation of sterically hindered aryloxyamines
AU2001286163A1 (en) An improved process for the preparation of 3-aryl-2-hydroxy propanoic acid derivatives
WO2002043715A3 (en) Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontinence
WO2002043714A3 (en) Use of substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence
CA2309485A1 (en) New 4-arylpiperidine derivatives for the treatment of pruritus

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载